drugset / Trial / NCT05230381
Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Intra-operative blood loss of huge meningioma resection patients on average was over 1000ml. Intra-operative massive hemorrhage was associated with longer hospital of stay, higher expense, and higher mortality. Previous studies indicated intra-operative tranexamic acid infusion would decrease blood loss for cardiac, trauma and obstetric procedures. However, limited researches focusing on the effect of tranexamic acid in neurosurgery population, with heterogenous pathologies. The purpose of this study was to investigate the effect of tranexamic acid on intra-operative blood loss in patients undergoing huge meningioma resection.
Timeline
- Start
- 2022-06-15
- Primary completion
- 2024-12-30
- Completion
- 2025-06-30
Publications
- Li S, Liu M, Zhang L, Ren Y, Wu Y, Yin X, Zeng M, Zhou D, Sessler DI, Peng Y. Effect of tranexamic acid on blood loss in patients undergoing resection of large meningioma: a randomized clinical trial. Sci Rep. 2026 May 11;16(1):21458. doi: 10.1038/s41598-026-52276-2.
- Yu H, Liu M, Zhang X, Ma T, Yang J, Wu Y, Wang J, Li M, Wang J, Zeng M, Zhang L, Jin H, Liu X, Li S, Peng Y. The effect of tranexamic acid on intraoperative blood loss in patients undergoing brain meningioma resections: Study protocol for a randomized controlled trial. PLoS One. 2023 Aug 31;18(8):e0290725. doi: 10.1371/journal.pone.0290725. eCollection 2023.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 5 mg/kg | Intravenous |
| Comparator | Tranexamic Acid | Small molecule | 20 mg/kg | Intravenous |